0.06 (-226.19%)
As of Apr 04, 2023
Source:
Codiak Biosciences, Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 617-949-4100 |
| Industry | manufacturing |
| CEO | Douglas E. Williams |
| Website |